Angiotensin 1-7 stimulates brown adipose tissue and reduces diet-induced obesity. 2018

Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science , Kyoto , Japan.

The renin-angiotensin system is a key regulator of metabolism with beneficial effects of the angiotensin 1-7 (Ang 1-7) peptide. We hypothesized that the antiobesity effect of Ang 1-7 was related to the stimulation of brown adipose tissue (BAT). We administered Ang 1-7 (0.54 mg kg-1 day-1) for 28 days via implanted micro-osmotic pumps to mice with high-fat diet (HFD)-induced obesity. Ang 1-7 treatment reduced body weight, upregulated thermogenesis, and ameliorated impaired glucose homeostasis without affecting food consumption. Furthermore, Ang 1-7 treatment enlarged BAT and the increased expression of UCP1, PRDM16, and prohibitin. Alterations in PRDM16 expression correlated with increased AMPK and phosphorylation of mTOR. Ang 1-7 treatment elevated thermogenesis in subcutaneous white adipose tissue without altering UCP1 expression. These changes occurred in the context of decreased lipid accumulation in BAT from HFD-fed mice, preserved insulin signaling concomitant with phosphorylation of hormone-sensitive lipase and decreased expression of perilipin. These data suggest that Ang 1-7 induces brown adipocyte differentiation leading to upregulation of thermogenesis and improved metabolic profile in diet-induced obesity. Enhancing Ang 1-7 action represents a promising therapy to increase BAT and to reduce the metabolic complications associated with diet-induced obesity.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002001 Adipose Tissue, Brown A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids. Brown Fat,Hibernating Gland,Brown Adipose Tissue,Fat, Brown,Tissue, Brown Adipose
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
January 2013, PloS one,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
July 1987, The American journal of physiology,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
September 2015, Obesity (Silver Spring, Md.),
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
February 1981, Nature,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
January 2019, Biological & pharmaceutical bulletin,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
January 2017, Obesity research & clinical practice,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
January 2024, Molecular metabolism,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
May 2017, International journal of obesity (2005),
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
June 1985, The American journal of physiology,
Hidechika Morimoto, and Jun Mori, and Hisakazu Nakajima, and Yasuhiro Kawabe, and Yusuke Tsuma, and Shota Fukuhara, and Kazuki Kodo, and Kazuya Ikoma, and Satoaki Matoba, and Gavin Y Oudit, and Hajime Hosoi
August 2021, Nature communications,
Copied contents to your clipboard!